Relaxation and sleep compression for late-life insomnia: A placebo-controlled trial.

2001 ◽  
Vol 69 (2) ◽  
pp. 227-239 ◽  
Author(s):  
Kenneth L. Lichstein ◽  
Brant W. Riedel ◽  
Nancy M. Wilson ◽  
Kristin W. Lester ◽  
R. Neal Aguillard
Keyword(s):  
Controlled Trial ◽  
Late Life

scholarly journals UTILIZING NUTRITION SERVICES PROVIDERS TO PREVENT LATE-LIFE SUICIDE: IMPLEMENTING A RANDOMIZED, CONTROLLED TRIAL

2019 ◽  
Vol 3 (Supplement_1) ◽  
pp. S824-S825
Author(s):  
Matthew C Fullen ◽  
Mary Chase Mize ◽  
Laura R Shannonhouse
Keyword(s):  
Randomized Controlled Trial ◽  
Suicide Prevention ◽  
Controlled Trial ◽  
Late Life ◽  
Warning Signs ◽  
Community Based ◽  
Randomized Controlled ◽  
Nutrition Services ◽  
Suicide Prevention Training ◽  
The Impact

Abstract A challenge in preventing late-life suicide is identifying and responding to persons-at-risk prior to a suicide attempt. Distressed older adults are less likely to turn to a mental health professional, meaning that community-based prevention strategies are vitally important to comprehensive prevention frameworks. Due to their “natural helper” role, nutrition services (NS) volunteers may be well-positioned to identify suicide warning signs and respond accordingly. Unfortunately, there is a lack of systematic, empirically-tested evaluations of the effectiveness of community-based strategies to prevent older adult suicide, including the use of NS volunteers. To remedy this, the authors partnered with several home- and community-based service organizations to measure the impact of training nutrition services volunteers in suicide prevention skills. The authors will present preliminary findings from this federally-funded randomized, controlled trial of suicide prevention training (i.e., ASIST; safeTALK) on late-life suicidality and its correlates.

scholarly journals A Randomized Controlled Trial of Telephone-Delivered Cognitive-Behavioral Therapy for Late-Life Anxiety Disorders

2012 ◽  
Vol 20 (8) ◽  
pp. 707-716 ◽  
Author(s):  
Gretchen A. Brenes ◽  
Michael E. Miller ◽  
Jeff D. Williamson ◽  
W. Vaughn McCall ◽  
Mark Knudson ◽  
...  
Keyword(s):  
Randomized Controlled Trial ◽  
Cognitive Behavioral Therapy ◽  
Anxiety Disorders ◽  
Behavioral Therapy ◽  
Controlled Trial ◽  
Late Life ◽  
Cognitive Behavioral ◽  
Randomized Controlled

Efficacy and Tolerability of Citalopram in the Treatment of Late-Life Anxiety Disorders: Results From an 8-Week Randomized, Placebo-Controlled Trial

2005 ◽  
Vol 162 (1) ◽  
pp. 146-150 ◽  
Author(s):  
Eric J. Lenze ◽  
Benoit H. Mulsant ◽  
M. Katherine Shear ◽  
Mary Amanda Dew ◽  
Mark D. Miller ◽  
...  
Keyword(s):  
Anxiety Disorders ◽  
Controlled Trial ◽  
Late Life

Collaborative care for primary care treatment of late‐life depression in Singapore: Randomized controlled trial

2020 ◽  
Vol 35 (10) ◽  
pp. 1171-1180
Author(s):  
Tze Pin Ng ◽  
Ma S. Z. Nyunt ◽  
Liang Feng ◽  
Rajeev Kumar ◽  
Calvin S. L. Fones ◽  
...  
Keyword(s):  
Primary Care ◽  
Randomized Controlled Trial ◽  
Collaborative Care ◽  
Controlled Trial ◽  
Late Life ◽  
Late Life Depression ◽  
Randomized Controlled ◽  
Care Treatment

The effect of cataract surgery on neuropsychological test performance: A randomized controlled trial

2006 ◽  
Vol 12 (5) ◽  
pp. 632-639 ◽  
Author(s):  
KAARIN J. ANSTEY ◽  
STEPHEN R. LORD ◽  
MICHAEL HENNESSY ◽  
PAUL MITCHELL ◽  
KATHERINE MILL ◽  
...  
Keyword(s):  
Cognitive Function ◽  
Cataract Surgery ◽  
Cognitive Performance ◽  
Test Performance ◽  
Visual Function ◽  
Controlled Trial ◽  
Neuropsychological Test ◽  
Late Life ◽  
Cognitive Testing ◽  
Cross Sectional

Recent cross-sectional studies have reported strong associations between visual and cognitive function, and longitudinal studies have shown relationships between visual and cognitive decline in late life. Improvement in cognitive performance after cataract surgery has been reported in patients with Mild Cognitive Impairment. We investigated whether improving visual function with cataract surgery would improve neuropsychological performance in healthy older adults. A randomized clinical trial of cataract surgery performed at acute hospitals was conducted on 56 patients (mean age 73) with bilateral cataract, after excluding a total of 54 patients at the screening stage, of whom 53 did not meet visual acuity criteria and one did not have cataract. In-home assessments included visual and neuropsychological function, computerized cognitive testing and health questionnaires. Results showed no cognitive benefits of cataract surgery in cognitively normal adults. We conclude that visual improvement following cataract surgery is not strongly associated with an improvement in neuropsychological test performance in otherwise healthy adults. Joint associations between visual and cognitive function in late life are likely to be due to central factors, and unlikely to be strongly related to eye disease. Short-term increased neural stimulation from improved visual function does not appear to affect cognitive performance. (JINS, 2006, 12, 632–639.)

scholarly journals Behavioural activation by mental health nurses for late-life depression in primary care: a randomized controlled trial

2017 ◽  
Vol 17 (1) ◽  
Author(s):  
Noortje Janssen ◽  
Marcus J.H. Huibers ◽  
Peter Lucassen ◽  
Richard Oude Voshaar ◽  
Harm van Marwijk ◽  
...  
Keyword(s):  
Mental Health ◽  
Primary Care ◽  
Randomized Controlled Trial ◽  
Controlled Trial ◽  
Late Life ◽  
Behavioural Activation ◽  
Late Life Depression ◽  
Mental Health Nurses ◽  
Randomized Controlled

scholarly journals Sahaj Samadhi meditation vs a Health Enhancement Program in improving late-life depression severity and executive function: study protocol for a two-site, randomized controlled trial

Trials ◽  
2019 ◽  
Vol 20 (1) ◽  
Author(s):  
Stephen Benjamin Peckham ◽  
Emily Ionson ◽  
Marouane Nassim ◽  
Kevin Ojha ◽  
Lena Palaniyappan ◽  
...  
Keyword(s):  
Randomized Controlled Trial ◽  
Executive Functioning ◽  
Controlled Trial ◽  
Late Life ◽  
Care Providers ◽  
Depression Severity ◽  
Late Life Depression ◽  
Randomized Controlled ◽  
Increased Risk ◽  
Augmentation Strategy

Abstract Background Recent estimates suggest an 11% prevalence of current late-life depression (LLD) and a lifetime prevalence of 16–20%. LLD leads to cognitive disturbance as well as a nearly two to three times increased risk of dementia. We conducted a recent randomized controlled trial (RCT) which demonstrated that Sahaj Samadhi meditation (SSM), an easy-to-implement, meditation-based augmentation strategy, led to higher rates of symptom remission when compared to treatment as usual (40.0 vs 16.3%; odds ratio, 3.36; 95% CI 1.06–10.64; p = 0.040). Here we present a protocol describing a two-site, blinded, RCT, comparing an SSM arm to an active-control arm – a Health Enhancement Program (HEP) intervention – in their ability to reduce depressive symptoms and improve executive functioning, among several other exploratory outcomes. Methods/design One hundred and ninety-two (n = 192) participants with LLD will be recruited at two sites (London, ON, Canada, and Montreal, QC, Canada). Participants will undergo stratified randomization with regards to site and the presence of treatment-resistant-LLD (TR-LLD) or not, to either SSM or HEP. We will assess change in (1) depression severity using the Hamilton Depression Rating Scale (HAM-D), (2) executive functioning, and (3) other exploratory physiological and mood-based measures, at baseline (0 weeks), post intervention (12 weeks), and 26 weeks after baseline. Raters, clinicians, and care providers will be blinded to group allocation while participants will be blinded to the study hypotheses. Discussion This study should more definitively assess whether SSM can be used as an augmentation strategy in routine clinical care for patients suffering from LLD and TR-LLD. If the effects of SSM are significantly better than HEP, it will offer support for the routine use of this intervention to manage LLD/TR-LLD and comorbid declines in executive dysfunction. The results of this study could also inform whether SSM can improve/prevent cognitive decline in LLD. Trial registration ClinicalTrials.gov, ID: NCT03564041. Registered on 20 June 2018.

Sign in / Sign up

Export Citation Format

Share Document